IMMU logo
Immunomedics, Inc.(IMMU)
$87.86Stale · 2.1 years old
Ask SAChart
9/15/26

IMMU (IMMU)

Tuesday
2:19 PM
ThesisIMMU: the story is balanced.

Revenue Outlook

FY2018 Snapshot
Net Margin
-12701%
NI Growth
-78.7%
EPS
$-1.78

IMMU Chart

No chart data

One Sentence Summary:

IMMU: the story is balanced — no single dominant catalyst right now.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.